MODIFIED NUCLEOSIDES, ANALOGS THEREOF AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM
申请人:ISIS PHARMACEUTICALS, INC.
公开号:US20150159163A1
公开(公告)日:2015-06-11
The present invention provides modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom. More particularly, the present invention provides modified nucleosides and analogs thereof that are useful for incorporation at the terminus of an oligomeric compound. Such oligomeric compounds can also be included in a double stranded composition. In some embodiments, the oligomeric compounds provided herein are expected to hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA.
本发明提供了改性核苷、类似物以及由其制备的寡核苷酸化合物。更具体地,本发明提供了可用于在寡核苷酸化合物的末端插入的改性核苷和类似物。这样的寡核苷酸化合物也可以包含在双链组成中。在某些实施例中,本文所提供的寡核苷酸化合物预计能够与靶RNA的一部分杂交,导致靶RNA的正常功能丧失。